Antag Therapeutics
Antag Therapeutics is a Software & Developer Tools startup based in Denmark, most recent round Series A, 1 tracked investor.
About Antag Therapeutics
Antag Therapeutics is a startup founded in 2023 based in Denmark. Its most recent tracked round is Series A. Brouky classifies it under Software & Developer Tools. Brouky records 1 investor associated with the company.
Antag Therapeutics is a biopharmaceutical company focused on developing treatments for obesity and related metabolic disorders through GIP receptor antagonism. Its lead candidate, AT7687, is a first-in-class peptide-based therapy designed to block biological pathways contributing to fat storage and insulin resistance.
Explore Antag Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.